Developed by doctors, strictly laboratory tested
Studies have shown that it aids in the metabolism of carbohydrates, fats, and proteins, contributing to energy production and overall metabolic health
WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
L-Carnitine: Supports fat burning Aids in healthy weight management Converts fat into energy Helps balance blood sugar levels Boosts physical performance Reduces muscle soreness Fights fatigue + keeps energy levels up all day
While individuals who are not overweight can suffer from a chronic disease, obesity is a significant risk factor for many chronic illnesses, from heart disease and diabetes to cancer and Alzheimers